Dermatomyositis sine myositis and antisynthetase syndrome.
Identifieur interne : 000448 ( PubMed/Checkpoint ); précédent : 000447; suivant : 000449Dermatomyositis sine myositis and antisynthetase syndrome.
Auteurs : Ana Climent-Albaladejo [Espagne] ; Encarnacion Saiz-Cuenca ; Juan Rosique-Roman ; Julian Caballero-Rodriguez ; Jose Galvez-MunozSource :
- Joint bone spine [ 1297-319X ] ; 2002.
Descripteurs français
- KwdFr :
- Anti-inflammatoires non stéroïdiens (usage thérapeutique), Anticorps antinucléaires (immunologie), Antirhumatismaux (usage thérapeutique), Arthrite (anatomopathologie), Arthrite (immunologie), Chloroquine (usage thérapeutique), Dermatomyosite (anatomopathologie), Dermatomyosite (immunologie), Dermatomyosite (traitement médicamenteux), Femelle, Humains, Maladie de Raynaud (anatomopathologie), Maladie de Raynaud (immunologie), Myosite (anatomopathologie), Myosite (immunologie), Pneumopathies interstitielles (anatomopathologie), Pneumopathies interstitielles (immunologie), Prednisone (usage thérapeutique), Résultat thérapeutique, Sujet âgé, Syndrome.
- MESH :
- anatomopathologie : Arthrite, Dermatomyosite, Maladie de Raynaud, Myosite, Pneumopathies interstitielles.
- immunologie : Anticorps antinucléaires, Arthrite, Dermatomyosite, Maladie de Raynaud, Myosite, Pneumopathies interstitielles.
- traitement médicamenteux : Dermatomyosite.
- usage thérapeutique : Anti-inflammatoires non stéroïdiens, Antirhumatismaux, Chloroquine, Prednisone.
- Femelle, Humains, Résultat thérapeutique, Sujet âgé, Syndrome.
English descriptors
- KwdEn :
- Aged, Anti-Inflammatory Agents, Non-Steroidal (therapeutic use), Antibodies, Antinuclear (immunology), Antirheumatic Agents (therapeutic use), Arthritis (immunology), Arthritis (pathology), Chloroquine (therapeutic use), Dermatomyositis (drug therapy), Dermatomyositis (immunology), Dermatomyositis (pathology), Female, Humans, Lung Diseases, Interstitial (immunology), Lung Diseases, Interstitial (pathology), Myositis (immunology), Myositis (pathology), Prednisone (therapeutic use), Raynaud Disease (immunology), Raynaud Disease (pathology), Syndrome, Treatment Outcome.
- MESH :
- chemical , immunology : Antibodies, Antinuclear.
- chemical , therapeutic use : Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Chloroquine, Prednisone.
- drug therapy : Dermatomyositis.
- immunology : Arthritis, Dermatomyositis, Lung Diseases, Interstitial, Myositis, Raynaud Disease.
- pathology : Arthritis, Dermatomyositis, Lung Diseases, Interstitial, Myositis, Raynaud Disease.
- Aged, Female, Humans, Syndrome, Treatment Outcome.
Abstract
We describe a 66-year-old woman with cutaneous lesions typical of classic dermatomyositis, clinical evidence of antisynthetase syndrome (arthritis, Raynaud's phenomenon, mechanic's hands and interstitial lung disease with anti-Jo-1 autoantibody) and lack of muscle disease after a full muscle evaluation that included clinical, enzymatic, electromyographic, magnetic resonance imaging and histological studies. The patient did not develop myositis after 9 years of clinical disease. The association of dermatomyositis sine myositis with antisynthetase antibodies suggests that the characteristic skin lesions are closely linked with dermatomyositis on the basis of the similar clinical and serological features of both dermatomyositis sine myositis and classic dermatomyositis.
DOI: 10.1016/s1297-319x(01)00345-1
PubMed: 11858361
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:11858361Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dermatomyositis sine myositis and antisynthetase syndrome.</title><author><name sortKey="Climent Albaladejo, Ana" sort="Climent Albaladejo, Ana" uniqKey="Climent Albaladejo A" first="Ana" last="Climent-Albaladejo">Ana Climent-Albaladejo</name><affiliation wicri:level="1"><nlm:affiliation>Rheumatology unit, Hospital General Universitario Morales Meseguer, Murcia, Spain. Zuniga@um.es</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Rheumatology unit, Hospital General Universitario Morales Meseguer, Murcia</wicri:regionArea><wicri:noRegion>Murcia</wicri:noRegion></affiliation></author><author><name sortKey="Saiz Cuenca, Encarnacion" sort="Saiz Cuenca, Encarnacion" uniqKey="Saiz Cuenca E" first="Encarnacion" last="Saiz-Cuenca">Encarnacion Saiz-Cuenca</name></author><author><name sortKey="Rosique Roman, Juan" sort="Rosique Roman, Juan" uniqKey="Rosique Roman J" first="Juan" last="Rosique-Roman">Juan Rosique-Roman</name></author><author><name sortKey="Caballero Rodriguez, Julian" sort="Caballero Rodriguez, Julian" uniqKey="Caballero Rodriguez J" first="Julian" last="Caballero-Rodriguez">Julian Caballero-Rodriguez</name></author><author><name sortKey="Galvez Munoz, Jose" sort="Galvez Munoz, Jose" uniqKey="Galvez Munoz J" first="Jose" last="Galvez-Munoz">Jose Galvez-Munoz</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:11858361</idno><idno type="pmid">11858361</idno><idno type="doi">10.1016/s1297-319x(01)00345-1</idno><idno type="wicri:Area/PubMed/Corpus">000472</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000472</idno><idno type="wicri:Area/PubMed/Curation">000472</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000472</idno><idno type="wicri:Area/PubMed/Checkpoint">000448</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000448</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Dermatomyositis sine myositis and antisynthetase syndrome.</title><author><name sortKey="Climent Albaladejo, Ana" sort="Climent Albaladejo, Ana" uniqKey="Climent Albaladejo A" first="Ana" last="Climent-Albaladejo">Ana Climent-Albaladejo</name><affiliation wicri:level="1"><nlm:affiliation>Rheumatology unit, Hospital General Universitario Morales Meseguer, Murcia, Spain. Zuniga@um.es</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Rheumatology unit, Hospital General Universitario Morales Meseguer, Murcia</wicri:regionArea><wicri:noRegion>Murcia</wicri:noRegion></affiliation></author><author><name sortKey="Saiz Cuenca, Encarnacion" sort="Saiz Cuenca, Encarnacion" uniqKey="Saiz Cuenca E" first="Encarnacion" last="Saiz-Cuenca">Encarnacion Saiz-Cuenca</name></author><author><name sortKey="Rosique Roman, Juan" sort="Rosique Roman, Juan" uniqKey="Rosique Roman J" first="Juan" last="Rosique-Roman">Juan Rosique-Roman</name></author><author><name sortKey="Caballero Rodriguez, Julian" sort="Caballero Rodriguez, Julian" uniqKey="Caballero Rodriguez J" first="Julian" last="Caballero-Rodriguez">Julian Caballero-Rodriguez</name></author><author><name sortKey="Galvez Munoz, Jose" sort="Galvez Munoz, Jose" uniqKey="Galvez Munoz J" first="Jose" last="Galvez-Munoz">Jose Galvez-Munoz</name></author></analytic><series><title level="j">Joint bone spine</title><idno type="ISSN">1297-319X</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)</term><term>Antibodies, Antinuclear (immunology)</term><term>Antirheumatic Agents (therapeutic use)</term><term>Arthritis (immunology)</term><term>Arthritis (pathology)</term><term>Chloroquine (therapeutic use)</term><term>Dermatomyositis (drug therapy)</term><term>Dermatomyositis (immunology)</term><term>Dermatomyositis (pathology)</term><term>Female</term><term>Humans</term><term>Lung Diseases, Interstitial (immunology)</term><term>Lung Diseases, Interstitial (pathology)</term><term>Myositis (immunology)</term><term>Myositis (pathology)</term><term>Prednisone (therapeutic use)</term><term>Raynaud Disease (immunology)</term><term>Raynaud Disease (pathology)</term><term>Syndrome</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anti-inflammatoires non stéroïdiens (usage thérapeutique)</term><term>Anticorps antinucléaires (immunologie)</term><term>Antirhumatismaux (usage thérapeutique)</term><term>Arthrite (anatomopathologie)</term><term>Arthrite (immunologie)</term><term>Chloroquine (usage thérapeutique)</term><term>Dermatomyosite (anatomopathologie)</term><term>Dermatomyosite (immunologie)</term><term>Dermatomyosite (traitement médicamenteux)</term><term>Femelle</term><term>Humains</term><term>Maladie de Raynaud (anatomopathologie)</term><term>Maladie de Raynaud (immunologie)</term><term>Myosite (anatomopathologie)</term><term>Myosite (immunologie)</term><term>Pneumopathies interstitielles (anatomopathologie)</term><term>Pneumopathies interstitielles (immunologie)</term><term>Prednisone (usage thérapeutique)</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Syndrome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Antinuclear</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents, Non-Steroidal</term><term>Antirheumatic Agents</term><term>Chloroquine</term><term>Prednisone</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Arthrite</term><term>Dermatomyosite</term><term>Maladie de Raynaud</term><term>Myosite</term><term>Pneumopathies interstitielles</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dermatomyositis</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antinucléaires</term><term>Arthrite</term><term>Dermatomyosite</term><term>Maladie de Raynaud</term><term>Myosite</term><term>Pneumopathies interstitielles</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Arthritis</term><term>Dermatomyositis</term><term>Lung Diseases, Interstitial</term><term>Myositis</term><term>Raynaud Disease</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arthritis</term><term>Dermatomyositis</term><term>Lung Diseases, Interstitial</term><term>Myositis</term><term>Raynaud Disease</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Dermatomyosite</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires non stéroïdiens</term><term>Antirhumatismaux</term><term>Chloroquine</term><term>Prednisone</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Syndrome</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Femelle</term><term>Humains</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Syndrome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We describe a 66-year-old woman with cutaneous lesions typical of classic dermatomyositis, clinical evidence of antisynthetase syndrome (arthritis, Raynaud's phenomenon, mechanic's hands and interstitial lung disease with anti-Jo-1 autoantibody) and lack of muscle disease after a full muscle evaluation that included clinical, enzymatic, electromyographic, magnetic resonance imaging and histological studies. The patient did not develop myositis after 9 years of clinical disease. The association of dermatomyositis sine myositis with antisynthetase antibodies suggests that the characteristic skin lesions are closely linked with dermatomyositis on the basis of the similar clinical and serological features of both dermatomyositis sine myositis and classic dermatomyositis.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11858361</PMID><DateCompleted><Year>2002</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1297-319X</ISSN><JournalIssue CitedMedium="Print"><Volume>69</Volume><Issue>1</Issue><PubDate><Year>2002</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Joint bone spine</Title><ISOAbbreviation>Joint Bone Spine</ISOAbbreviation></Journal><ArticleTitle>Dermatomyositis sine myositis and antisynthetase syndrome.</ArticleTitle><Pagination><MedlinePgn>72-5</MedlinePgn></Pagination><Abstract><AbstractText>We describe a 66-year-old woman with cutaneous lesions typical of classic dermatomyositis, clinical evidence of antisynthetase syndrome (arthritis, Raynaud's phenomenon, mechanic's hands and interstitial lung disease with anti-Jo-1 autoantibody) and lack of muscle disease after a full muscle evaluation that included clinical, enzymatic, electromyographic, magnetic resonance imaging and histological studies. The patient did not develop myositis after 9 years of clinical disease. The association of dermatomyositis sine myositis with antisynthetase antibodies suggests that the characteristic skin lesions are closely linked with dermatomyositis on the basis of the similar clinical and serological features of both dermatomyositis sine myositis and classic dermatomyositis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Climent-Albaladejo</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rheumatology unit, Hospital General Universitario Morales Meseguer, Murcia, Spain. Zuniga@um.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saiz-Cuenca</LastName><ForeName>Encarnacion</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Rosique-Roman</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Caballero-Rodriguez</LastName><ForeName>Julian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Galvez-Munoz</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Joint Bone Spine</MedlineTA><NlmUniqueID>100938016</NlmUniqueID><ISSNLinking>1297-319X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C046750">Jo-1 antibody</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>VB0R961HZT</RegistryNumber><NameOfSubstance UI="D011241">Prednisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001168" MajorTopicYN="N">Arthritis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003882" MajorTopicYN="N">Dermatomyositis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017563" MajorTopicYN="N">Lung Diseases, Interstitial</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009220" MajorTopicYN="N">Myositis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011241" MajorTopicYN="N">Prednisone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011928" MajorTopicYN="N">Raynaud Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>2</Month><Day>23</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>8</Month><Day>8</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>2</Month><Day>23</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11858361</ArticleId><ArticleId IdType="doi">10.1016/s1297-319x(01)00345-1</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country></list><tree><noCountry><name sortKey="Caballero Rodriguez, Julian" sort="Caballero Rodriguez, Julian" uniqKey="Caballero Rodriguez J" first="Julian" last="Caballero-Rodriguez">Julian Caballero-Rodriguez</name><name sortKey="Galvez Munoz, Jose" sort="Galvez Munoz, Jose" uniqKey="Galvez Munoz J" first="Jose" last="Galvez-Munoz">Jose Galvez-Munoz</name><name sortKey="Rosique Roman, Juan" sort="Rosique Roman, Juan" uniqKey="Rosique Roman J" first="Juan" last="Rosique-Roman">Juan Rosique-Roman</name><name sortKey="Saiz Cuenca, Encarnacion" sort="Saiz Cuenca, Encarnacion" uniqKey="Saiz Cuenca E" first="Encarnacion" last="Saiz-Cuenca">Encarnacion Saiz-Cuenca</name></noCountry><country name="Espagne"><noRegion><name sortKey="Climent Albaladejo, Ana" sort="Climent Albaladejo, Ana" uniqKey="Climent Albaladejo A" first="Ana" last="Climent-Albaladejo">Ana Climent-Albaladejo</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000448 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000448 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:11858361
|texte= Dermatomyositis sine myositis and antisynthetase syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:11858361" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |